These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 33497480

  • 1. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
    Katanga J, Kjaer SK, Manongi R, Pembe AB, Iftner T, Waldstrom M, Mwaiselage J, Rasch V.
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):786-793. PubMed ID: 33497480
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.
    Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT.
    Lancet Oncol; 2008 Oct; 9(10):929-36. PubMed ID: 18805733
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
    Tuerxun G, Yukesaier A, Lu L, Aierken K, Mijiti P, Jiang Y, Abulizi A, Zhang Y, Abuduxikuer G, Abulizi G, Li H.
    Oncologist; 2016 Jul; 21(7):825-31. PubMed ID: 27317575
    [Abstract] [Full Text] [Related]

  • 5. A parallel study of careHPV and Hybrid Capture 2 human papillomavirus DNA testing for cervical cancer screening in rural China.
    Lin CQ, Chen F, Liu B, Zhang YZ, Cui XL, Li AM, Zhang WH, Chen W, Chang I, Sivasubramaniam P, Zhu J, Qiao YL.
    J Virol Methods; 2014 Jun; 202():73-8. PubMed ID: 24642241
    [Abstract] [Full Text] [Related]

  • 6. The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.
    Chen W, Jeronimo J, Zhao FH, Qiao YL, Valdez M, Zhang X, Kang LN, Bansil P, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.
    J Clin Virol; 2014 Dec; 61(4):553-7. PubMed ID: 25453572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.
    Segondy M, Kelly H, Magooa MP, Djigma F, Ngou J, Gilham C, Omar T, Goumbri-Lompo O, Michelow P, Doutre S, Clavero O, Chikandiwa A, Sawadogo B, Didelot MN, Costes V, Méda N, Delany-Moretlwe S, Mayaud P.
    Br J Cancer; 2016 Aug 09; 115(4):425-30. PubMed ID: 27434037
    [Abstract] [Full Text] [Related]

  • 9. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J, Gilham C, Omar T, Goumbri-Lompo O, Doutre S, Michelow P, Kelly H, Didelot MN, Chikandiwa A, Sawadogo B, Delany-Moretlwe S, Meda N, Costes V, Mayaud P, Segondy M.
    J Acquir Immune Defic Syndr; 2015 Feb 01; 68(2):162-8. PubMed ID: 25394189
    [Abstract] [Full Text] [Related]

  • 10. Concordance in HPV Detection Between Self-Collected and Health Provider-Collected Cervicovaginal Samples Using careHPV in Tanzanian Women.
    Katanga JJ, Rasch V, Manongi R, Pembe AB, Mwaiselage JD, Kjaer SK.
    JCO Glob Oncol; 2021 Jun 01; 7():985-991. PubMed ID: 34181439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.
    Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH.
    J Gynecol Oncol; 2017 Sep 01; 28(5):e66. PubMed ID: 28657227
    [Abstract] [Full Text] [Related]

  • 14. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 Sep 01; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA, Chikandiwa A, Sawadogo B, Gilham C, Michelow P, Lompo OG, Omar T, Zan S, Magooa P, Segondy M, Nagot N, Meda N, Delany-Moretlwe S, Mayaud P, HARP Study Group.
    PLoS Med; 2021 Mar 01; 18(3):e1003528. PubMed ID: 33661957
    [Abstract] [Full Text] [Related]

  • 16. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T, Ivanus U, Jerman T, Takac I, Arko D.
    Radiol Oncol; 2021 Jan 06; 55(2):187-195. PubMed ID: 33764704
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
    Mchome BL, Kjaer SK, Manongi R, Swai P, Waldstroem M, Iftner T, Wu C, Mwaiselage J, Rasch V.
    Sex Transm Infect; 2021 Feb 06; 97(1):56-62. PubMed ID: 32269071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE.
    Cancer Epidemiol; 2009 Dec 06; 33(6):446-50. PubMed ID: 19931499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.